Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) just unveiled an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has disclosed the current composition of its board, led by chairperson Li Xiaojun and vice chairperson Chen Jiehui, comprising five executive directors and four independent non-executive directors. The announcement clarifies governance responsibilities across four key board committees, detailing which directors chair or sit on the audit, strategic development and investment, nomination and remuneration, and budget committees, underscoring the company’s emphasis on structured oversight and independent supervision.
The board committees are chaired by different directors to separate powers, with independent non-executive directors taking leading roles in the audit, nomination and remuneration, and key oversight functions. This allocation of roles signals a continued alignment with Hong Kong corporate governance norms and provides investors and other stakeholders with greater transparency into the company’s decision‑making framework and checks and balances at board level.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$20.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company with limited liability established in the People’s Republic of China and listed in Hong Kong under H share stock code 00874. The group operates in the pharmaceutical industry, focusing on the development, production and sale of medicines and related healthcare products for domestic and international markets.
Average Trading Volume: 1,258,378
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.72B
For a thorough assessment of 0874 stock, go to TipRanks’ Stock Analysis page.